Discover the challenges of treating resistant vaginal thrush and the rise of non-albicans Candida species. Learn about new ...

A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in ...

Vaginal thrush is common, with three in every four women of reproductive age likely to be affected. But fungal infections are ...

A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in the prevalence of fungal infections caused by fungal Candida species, ...

Candida species ... Azoles, especially fluconazole, are widely used therapeutic options. Objective: This study investigates how C. glabrata adapts to fluconazole, with a focus on understanding the ...

In a new study, scientists have uncovered a powerful new use for abnormal cannabinoid (AbnCBD) derivatives. These unique ...

Effective from January 1, 2001, standard fluconazole prophylaxis for all ... which allow for rapid Candida albicans identification through the blue staining of the colonies after 48 hours ...

With prolonged use, concerns exist for the emergence of acquired fungal resistance and of Candida subspecies that are natively fluconazole-resistant (NFR), mostly Candida glabrata and Candida krusei.

Relative to individuals with poor sleep quality, those with sufficient sleep were 3 times more likely to experience antidepressant treatment response. Insufficient sleep is associated with poorer ...